SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

M Rinaldi-Carmona, Francis Barth, J Millan, +11

Journal of Pharmacology and Experimental Therapeutics

Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage

P Carayon, M Portier, D. Dussossoy, +5

Blood

p53 and RAS gene mutations in multiple myeloma.

M Portier, Jean‐Pierre Molès, G R Mazars, +4

PubMed

Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.

Bernard Klein, XG Zhang, M Jourdan, +6

PubMed

Hematological MalignancyTumor BiologyCytokineAutoimmune DiseaseMalignant Blood Disorder +13

SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist

M Portier, M Rinaldi-Carmona, Florence Pecceu, +5

Journal of Pharmacology and Experimental Therapeutics

IFN-alpha induces autocrine production of IL-6 in myeloma cell lines

M Jourdan, X G Zhang, M Portier, +3

The Journal of Immunology

gamma-Interferon in multiple myeloma: inhibition of interleukin-6 (IL- 6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro

M Portier, XG Zhang, Émilie Caron, +3

Blood

Transient protection by peripheral benzodiazepine receptors during the early events of ultraviolet light-induced apoptosis

P Stoebner, P Carayon, Pierre Casellas, +6

Cell Death and Differentiation

Photoreceptor CellUltraviolet Light-induced ApoptosisOphthalmologyPhotochemistryPeripheral Benzodiazepine Receptors +12

An antagonistic monoclonal antibody (B-N6) specific for the human neurotensin receptor-1

J.‐M. Ovigne, Claudine Vermot‐Desroches, Jean‐Claude Lecron, +4

Neuropeptides

HypertensionMedicineImmunologyPharmacologyNeuropeptide Receptor +6